Long-Term Human Response Following Subretinal Injection of Recombinant Adenoassociated Virus-sFlt-1 Vector

Research output

Research output per year 2016 2016 2017 2017

• 2 Article

Research output per year

Research output per year

Search results

• Article

  Gene Therapy in Neovascular Age-related Macular Degeneration: Three-Year Follow-up of a Phase 1 Randomized Dose Escalation Trial

  Constable, I. J., Lai, C. M., Magno, A. L., French, M. A., Barone, S. B., Schwartz, S. D., Blumenkranz, M. S., Degli-Esposti, M. A. & Rakoczy, E. P., 1 May 2017, In: American Journal of Ophthalmology. 177, p. 150-158 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Macular Degeneration 100%
  • Genetic Therapy 88%
  • Ranibizumab 50%
  • Eye 47%
  • Retreatment 47%
  45 Citations (Scopus)

• Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration

  Constable, I. J., Pierce, C. M., Lai, C. M., Magno, A. L., Degli-Esposti, M. A., French, M. A., McAllister, I. L., Butler, S., Barone, S. B., Schwartz, S. D., Blumenkranz, M. S. & Rakoczy, E. P., 1 Dec 2016, In: EBioMedicine. 14, p. 168-175 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Macular Degeneration, Age-Related, 1 100%
  • Safety 47%
  • Randomized Controlled Trials 37%
  • Ocular 35%
  • Biotechnology 29%
  93 Citations (Scopus)